Do analysts recommend QMCO or TACT?

Quantum currently has a consensus price target of $17.67, indicating a potential upside of 31.64%. Given Quantum's stronger consensus rating and higher possible upside, equities analysts plainly believe Quantum is more favorable than TransAct Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quantum 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media prefer QMCO or TACT?

In the previous week, Quantum and Quantum both had 1 articles in the media. Quantum's average media sentiment score of 0.84 beat TransAct Technologies' score of 0.00 indicating that Quantum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer TACT or ALOT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 AstroNova 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to TACT or ALOT?

In the previous week, AstroNova had 1 more articles in the media than TransAct Technologies. MarketBeat recorded 2 mentions for AstroNova and 1 mentions for TransAct Technologies. AstroNova's average media sentiment score of 0.63 beat TransAct Technologies' score of 0.00 indicating that AstroNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AstroNova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TACT or VTIX?

Virtuix has a consensus target price of $11.00, suggesting a potential upside of 251.44%. Given Virtuix's stronger consensus rating and higher possible upside, analysts clearly believe Virtuix is more favorable than TransAct Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Virtuix 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, TACT or VTIX?

Virtuix has lower revenue, but higher earnings than TransAct Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransAct Technologies $51.48M 1.07 -$1.24M -$0.05 N/A Virtuix $4.46M 20.22 N/A N/A N/A

Does the media prefer TACT or VTIX?

In the previous week, Virtuix had 3 more articles in the media than TransAct Technologies. MarketBeat recorded 4 mentions for Virtuix and 1 mentions for TransAct Technologies. Virtuix's average media sentiment score of 0.60 beat TransAct Technologies' score of 0.00 indicating that Virtuix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Virtuix 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend INVE or TACT?

Identiv currently has a consensus price target of $6.33, indicating a potential upside of 71.64%. Given Identiv's stronger consensus rating and higher probable upside, analysts clearly believe Identiv is more favorable than TransAct Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Identiv 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor INVE or TACT?

In the previous week, Identiv had 1 more articles in the media than TransAct Technologies. MarketBeat recorded 2 mentions for Identiv and 1 mentions for TransAct Technologies. Identiv's average media sentiment score of 0.75 beat TransAct Technologies' score of 0.00 indicating that Identiv is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Identiv 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate TACT or ZEPP?

Zepp Health has a consensus price target of $56.28, suggesting a potential upside of 1,164.72%. Given Zepp Health's stronger consensus rating and higher possible upside, analysts plainly believe Zepp Health is more favorable than TransAct Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransAct Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Zepp Health 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to TACT or ZEPP?

In the previous week, Zepp Health had 1 more articles in the media than TransAct Technologies. MarketBeat recorded 2 mentions for Zepp Health and 1 mentions for TransAct Technologies. TransAct Technologies' average media sentiment score of 0.00 equaled Zepp Health'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransAct Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zepp Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

TransAct Technologies (TACT) Competitors

$5.34 +0.28 (+5.53%)

Closing price 04:00 PM Eastern

Extended Trading

$5.34 +0.00 (+0.09%)

As of 07:21 PM Eastern

Compare

TACT vs. QMCO, ALOT, VTIX, INVE, and ZEPP

Should you buy TransAct Technologies stock or one of its competitors? MarketBeat compares TransAct Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TransAct Technologies include Quantum (QMCO), AstroNova (ALOT), Virtuix (VTIX), Identiv (INVE), and Zepp Health (ZEPP). These companies are all part of the "computer hardware" industry.

How does TransAct Technologies compare to Quantum?

Quantum (NASDAQ:QMCO) and TransAct Technologies (NASDAQ:TACT) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

63.7% of Quantum shares are held by institutional investors. Comparatively, 74.5% of TransAct Technologies shares are held by institutional investors. 0.9% of Quantum shares are held by company insiders. Comparatively, 19.2% of TransAct Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Quantum has a beta of 2.97, indicating that its stock price is 197% more volatile than the broader market. Comparatively, TransAct Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

Quantum currently has a consensus price target of $17.67, indicating a potential upside of 31.64%. Given Quantum's stronger consensus rating and higher possible upside, equities analysts plainly believe Quantum is more favorable than TransAct Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

TransAct Technologies has a net margin of -0.93% compared to Quantum's net margin of -37.76%. Quantum's return on equity of 0.00% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum	-37.76%	N/A	-21.66%
TransAct Technologies	-0.93%	-1.56%	-1.08%

In the previous week, Quantum and Quantum both had 1 articles in the media. Quantum's average media sentiment score of 0.84 beat TransAct Technologies' score of 0.00 indicating that Quantum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TransAct Technologies has lower revenue, but higher earnings than Quantum. TransAct Technologies is trading at a lower price-to-earnings ratio than Quantum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum	$274.06M	0.72	-$115.09M	-$2.36	N/A
TransAct Technologies	$51.48M	1.07	-$1.24M	-$0.05	N/A

Summary

Quantum beats TransAct Technologies on 8 of the 15 factors compared between the two stocks.

How does TransAct Technologies compare to AstroNova?

TransAct Technologies (NASDAQ:TACT) and AstroNova (NASDAQ:ALOT) are both small-cap computer hardware companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

74.5% of TransAct Technologies shares are owned by institutional investors. Comparatively, 43.0% of AstroNova shares are owned by institutional investors. 19.2% of TransAct Technologies shares are owned by company insiders. Comparatively, 12.6% of AstroNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
AstroNova	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, AstroNova had 1 more articles in the media than TransAct Technologies. MarketBeat recorded 2 mentions for AstroNova and 1 mentions for TransAct Technologies. AstroNova's average media sentiment score of 0.63 beat TransAct Technologies' score of 0.00 indicating that AstroNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AstroNova	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AstroNova has a net margin of -0.88% compared to TransAct Technologies' net margin of -0.93%. AstroNova's return on equity of 2.94% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.93%	-1.56%	-1.08%
AstroNova	-0.88%	2.94%	1.61%

TransAct Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, AstroNova has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market.

TransAct Technologies has higher earnings, but lower revenue than AstroNova. AstroNova is trading at a lower price-to-earnings ratio than TransAct Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$51.48M	1.07	-$1.24M	-$0.05	N/A
AstroNova	$150.51M	1.47	-$2.38M	-$0.18	N/A

Summary

TransAct Technologies and AstroNova tied by winning 7 of the 14 factors compared between the two stocks.

How does TransAct Technologies compare to Virtuix?

TransAct Technologies (NASDAQ:TACT) and Virtuix (NASDAQ:VTIX) are both small-cap computer hardware companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

74.5% of TransAct Technologies shares are owned by institutional investors. 19.2% of TransAct Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Virtuix has a consensus target price of $11.00, suggesting a potential upside of 251.44%. Given Virtuix's stronger consensus rating and higher possible upside, analysts clearly believe Virtuix is more favorable than TransAct Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Virtuix	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Virtuix has lower revenue, but higher earnings than TransAct Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$51.48M	1.07	-$1.24M	-$0.05	N/A
Virtuix	$4.46M	20.22	N/A	N/A	N/A

In the previous week, Virtuix had 3 more articles in the media than TransAct Technologies. MarketBeat recorded 4 mentions for Virtuix and 1 mentions for TransAct Technologies. Virtuix's average media sentiment score of 0.60 beat TransAct Technologies' score of 0.00 indicating that Virtuix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Virtuix	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Virtuix has a net margin of 0.00% compared to TransAct Technologies' net margin of -0.93%. Virtuix's return on equity of 0.00% beat TransAct Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.93%	-1.56%	-1.08%
Virtuix	N/A	N/A	N/A

Summary

Virtuix beats TransAct Technologies on 9 of the 12 factors compared between the two stocks.

How does TransAct Technologies compare to Identiv?

Identiv (NASDAQ:INVE) and TransAct Technologies (NASDAQ:TACT) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

Identiv has a beta of 1.19, indicating that its stock price is 19% more volatile than the broader market. Comparatively, TransAct Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

65.2% of Identiv shares are owned by institutional investors. Comparatively, 74.5% of TransAct Technologies shares are owned by institutional investors. 3.6% of Identiv shares are owned by insiders. Comparatively, 19.2% of TransAct Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Identiv had 1 more articles in the media than TransAct Technologies. MarketBeat recorded 2 mentions for Identiv and 1 mentions for TransAct Technologies. Identiv's average media sentiment score of 0.75 beat TransAct Technologies' score of 0.00 indicating that Identiv is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Identiv	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Identiv currently has a consensus price target of $6.33, indicating a potential upside of 71.64%. Given Identiv's stronger consensus rating and higher probable upside, analysts clearly believe Identiv is more favorable than TransAct Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Identiv	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

TransAct Technologies has a net margin of -0.93% compared to Identiv's net margin of -70.52%. TransAct Technologies' return on equity of -1.56% beat Identiv's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Identiv	-70.52%	-11.74%	-11.04%
TransAct Technologies	-0.93%	-1.56%	-1.08%

TransAct Technologies has higher revenue and earnings than Identiv. TransAct Technologies is trading at a lower price-to-earnings ratio than Identiv, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Identiv	$21.48M	4.12	-$18M	-$0.72	N/A
TransAct Technologies	$51.48M	1.07	-$1.24M	-$0.05	N/A

Summary

TransAct Technologies beats Identiv on 9 of the 16 factors compared between the two stocks.

How does TransAct Technologies compare to Zepp Health?

TransAct Technologies (NASDAQ:TACT) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

TransAct Technologies has higher earnings, but lower revenue than Zepp Health. TransAct Technologies is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransAct Technologies	$51.48M	1.07	-$1.24M	-$0.05	N/A
Zepp Health	$258.90M	0.25	-$40.07M	-$2.52	N/A

74.5% of TransAct Technologies shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 19.2% of TransAct Technologies shares are held by company insiders. Comparatively, 36.0% of Zepp Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Zepp Health had 1 more articles in the media than TransAct Technologies. MarketBeat recorded 2 mentions for Zepp Health and 1 mentions for TransAct Technologies. TransAct Technologies' average media sentiment score of 0.00 equaled Zepp Health'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransAct Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zepp Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zepp Health has a consensus price target of $56.28, suggesting a potential upside of 1,164.72%. Given Zepp Health's stronger consensus rating and higher possible upside, analysts plainly believe Zepp Health is more favorable than TransAct Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransAct Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

TransAct Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Zepp Health has a beta of 1.78, indicating that its stock price is 78% more volatile than the broader market.

TransAct Technologies has a net margin of -0.93% compared to Zepp Health's net margin of -14.70%. TransAct Technologies' return on equity of -1.56% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransAct Technologies	-0.93%	-1.56%	-1.08%
Zepp Health	-14.70%	-15.64%	-6.03%

Summary

Zepp Health beats TransAct Technologies on 8 of the 15 factors compared between the two stocks.

Get TransAct Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TACT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TACT vs. The Competition

Export

Metric	TransAct Technologies	COMP Industry	Computer Sector	NASDAQ Exchange
Market Cap	$52M	$1.85B	$38.34B	$12.32B
Dividend Yield	N/A	4.56%	3.30%	5.88%
P/E Ratio	-106.80	82.96	169.72	23.96
Price / Sales	1.07	4.45	625.79	107.90
Price / Cash	N/A	6.69	46.62	53.76
Price / Book	1.73	2.40	9.51	6.41
Net Income	-$1.24M	$84.65M	$1.07B	$337.14M
7 Day Performance	1.52%	-10.54%	0.36%	-0.48%
1 Month Performance	37.28%	-8.33%	3.10%	0.49%
1 Year Performance	46.70%	-6.95%	154.70%	28.16%

TransAct Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TACT TransAct Technologies	0.8395 of 5 stars	$5.34 +5.5%	N/A	+37.9%	$52M	$51.48M	N/A	120	News Coverage
QMCO Quantum	3.3586 of 5 stars	$14.41 +3.1%	$17.67 +22.6%	+68.6%	$204.49M	$274.06M	N/A	900
ALOT AstroNova	0.5353 of 5 stars	$16.69 +0.2%	N/A	+213.5%	$129.08M	$150.51M	N/A	340
VTIX Virtuix	3.6461 of 5 stars	$3.39 -0.3%	N/A	N/A	$97.67M	$4.46M	N/A	39	News Coverage
INVE Identiv	3.6552 of 5 stars	$3.84 -3.0%	$6.33 +64.9%	+19.4%	$95.07M	$21.48M	N/A	330	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TACT) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TransAct Technologies (TACT) Competitors

TACT vs. QMCO, ALOT, VTIX, INVE, and ZEPP

How does TransAct Technologies compare to Quantum?

Summary

How does TransAct Technologies compare to AstroNova?

Summary

How does TransAct Technologies compare to Virtuix?

Summary

How does TransAct Technologies compare to Identiv?

Summary

How does TransAct Technologies compare to Zepp Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACT vs. The Competition

TransAct Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TransAct Technologies (TACT) Competitors

TACT vs. QMCO, ALOT, VTIX, INVE, and ZEPP

How does TransAct Technologies compare to Quantum?

Do insiders and institutionals believe in QMCO or TACT?

Which has more risk and volatility, QMCO or TACT?

Do analysts recommend QMCO or TACT?

Is QMCO or TACT more profitable?

Does the media prefer QMCO or TACT?

Which has higher valuation & earnings, QMCO or TACT?

Summary

How does TransAct Technologies compare to AstroNova?

Do insiders & institutionals hold more shares of TACT or ALOT?

Do analysts prefer TACT or ALOT?

Does the media refer more to TACT or ALOT?

Is TACT or ALOT more profitable?

Which has more risk and volatility, TACT or ALOT?

Which has preferable earnings and valuation, TACT or ALOT?

Summary

How does TransAct Technologies compare to Virtuix?

Do insiders and institutionals have more ownership in TACT or VTIX?

Do analysts rate TACT or VTIX?

Which has higher earnings and valuation, TACT or VTIX?

Does the media prefer TACT or VTIX?

Is TACT or VTIX more profitable?

Summary

How does TransAct Technologies compare to Identiv?

Which has more risk & volatility, INVE or TACT?

Do insiders & institutionals believe in INVE or TACT?

Does the media favor INVE or TACT?

Do analysts recommend INVE or TACT?

Is INVE or TACT more profitable?

Which has higher valuation & earnings, INVE or TACT?

Summary

How does TransAct Technologies compare to Zepp Health?

Which has better earnings and valuation, TACT or ZEPP?

Do institutionals & insiders have more ownership in TACT or ZEPP?

Does the media refer more to TACT or ZEPP?

Do analysts rate TACT or ZEPP?

Which has more risk & volatility, TACT or ZEPP?

Is TACT or ZEPP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACT vs. The Competition

TransAct Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools